3-buten-2-one has been researched along with reversan in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaoka, N; Ibi, M; Ikuta, K; Iwata, K; Katsuyama, M; Liu, J; Matsumoto, M; Wen, X; Yabe-Nishimura, C; Zhang, X; Zhu, K | 1 |
1 other study(ies) available for 3-buten-2-one and reversan
| Article | Year |
|---|---|
NOX1/NADPH oxidase regulates the expression of multidrug resistance-associated protein 1 and maintains intracellular glutathione levels.
Topics: Acrolein; Animals; Butanones; Cell Survival; Cells, Cultured; CRISPR-Cas Systems; Gene Expression Regulation; Glutathione; Multidrug Resistance-Associated Proteins; Myocytes, Cardiac; NADPH Oxidase 1; Pyrazoles; Pyrimidines; Rats; Reactive Oxygen Species | 2019 |